Management of recurrent and metastatic oral cavity cancer: Raising the bar a step higher von Szturz, Petr, Vermorken, Jan B.

Volltext

Immunotherapy in head and neck cancer: aiming at EXTREME precision von Szturz, Petr, Vermorken, Jan B

Volltext

Management of locally recurrent nasopharyngeal carcinoma von Lee, Anne W.M., Ng, Wai Tong, Chan, Jimmy Y.W., Corry, June, Mäkitie, Antti, Mendenhall, William M., Rinaldo, Alessandra, Rodrigo, Juan P., Saba, Nabil F., Strojan, Primož, Suárez, Carlos, Vermorken, Jan B., Yom, Sue S., Ferlito, Alfio

Volltext

Weekly Low‐Dose Versus Three‐Weekly High‐Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non‐Nasopharyngeal Head and Neck Cancer: A Systematic Review and Me... von Szturz, Petr, Wouters, Kristien, Kiyota, Naomi, Tahara, Makoto, Prabhash, Kumar, Noronha, Vanita, Castro, Ana, Licitra, Lisa, Adelstein, David, Vermorken, Jan B.

Volltext

Overview of the efficacy of cetuximab in recurrent and/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum‐based therapies von Vermorken, Jan. B., Herbst, Roy S., Leon, Xavier, Amellal, Nadia, Baselga, Jose

Volltext

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 rando... von Vermorken, Jan B, Dr, Stöhlmacher-Williams, Jan, MD, Davidenko, Irina, MD, Licitra, Lisa, MD, Winquist, Eric, MD, Villanueva, Cristian, MD, Foa, Paolo, MD, Rottey, Sylvie, MD, Skladowski, Krzysztof, MD, Tahara, Makoto, MD, Pai, Vasant R, MD, Faivre, Sandrine, MD, Blajman, Cesar R, MD, Forastiere, Arlene A, MD, Stein, Brian N, MBBS, Oliner, Kelly S, PhD, Pan, Zhiying, PhD, Bach, Bruce A, MD

Volltext

Taxane-Cisplatin-Fluorouracil As Induction Chemotherapy in Locally Advanced Head and Neck Cancers: An Individual Patient Data Meta-Analysis of the Meta-Analysis of Chemotherapy in... von BLANCHARD, Pierre, BOURHIS, Jean, PIGNON, Jean-Pierre, LACAS, Benjamin, POSNER, Marshall R, VERMORKEN, Jan B, CRUZ HERNANDEZ, Juan J, BOURREDJEM, Abderrahmane, CALAIS, Gilles, PACCAGNELLA, Adriano, HITT, Ricardo

Volltext

Editorial: Head and neck cancer in the elderly von Szturz, Petr, Vermorken, Jan B

Volltext

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based t... von Machiels, Jean-Pascal H, Prof, Haddad, Robert I, MD, Fayette, Jérôme, MD, Licitra, Lisa F, MD, Tahara, Makoto, MD, Vermorken, Jan B, Prof, Clement, Paul M, Prof, Gauler, Thomas, MD, Cupissol, Didier, MD, Grau, Juan José, MD, Guigay, Joël, Prof, Caponigro, Francesco, MD, de Castro, Gilberto, PhD, de Souza Viana, Luciano, MD, Keilholz, Ulrich, Prof, del Campo, Joseph M, MD, Cong, Xiuyu Julie, PhD, Ehrnrooth, Eva, MD, Cohen, Ezra E W, MD

Volltext

Editorial: Insights in head and neck cancer: 2021 von Lybaert, Willem, Vermorken, Jan B

Volltext

Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer von Vermorken, Jan B, Mesia, Ricard, Rivera, Fernando, Remenar, Eva, Kawecki, Andrzej, Rottey, Sylvie, Erfan, Jozsef, Zabolotnyy, Dmytro, Kienzer, Heinz-Roland, Cupissol, Didier, Peyrade, Frederic, Benasso, Marco, Vynnychenko, Ihor, De Raucourt, Dominique, Bokemeyer, Carsten, Schueler, Armin, Amellal, Nadia, Hitt, Ricardo

Volltext

Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell... von VERMORKEN, Jan B, TRIGO, José, HITT, Ricardo, KORALEWSKI, Piotr, DIAZ-RUBIO, Eduardo, ROLLAND, Frédéric, KNECHT, Rainald, AMELLAL, Nadia, SCHUELER, Armin, BASELGA, José

Volltext

Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer von Vermorken, Jan B, Remenar, Eva, van Herpen, Carla, Gorlia, Thierry, Mesia, Ricard, Degardin, Marian, Stewart, John S, Jelic, Svetislav, Betka, Jan, Preiss, Joachim H, van den Weyngaert, Danielle, Awada, Ahmad, Cupissol, Didier, Kienzer, Heinz R, Rey, Augustin, Desaunois, Isabelle, Bernier, Jacques, Lefebvre, Jean-Louis

Volltext

Abagovomab As Maintenance Therapy in Patients With Epithelial Ovarian Cancer: A Phase III Trial of the AGO OVAR, COGI, GINECO, and GEICO—The MIMOSA Study von SABBATINI, Paul, HARTER, Philipp, BIDZINSKI, Mariusz, CASADO, Antonio, MARTONI, Andrea, COLOMBO, Nicoletta, HOLLOWAY, Robert W, SELVAGGI, Luigi, LI, Andrew, DEL CAMPO, Jose, CWIERTKA, Karel, PINTER, Tamas, SCAMBIA, Giovanni, VERMORKEN, Jan B, PUJADE-LAURAINE, Eric, SCARTONI, Simona, BERTOLOTTI, Monica, SIMONELLI, Cecilia, CAPRIATI, Angela, MAGGI, Carlo Alberto, BEREK, Jonathan S, PFISTERER, Jacobus, SEHOULI, Jalid, MEIER, Werner, WIMBERGER, Pauline, BAUMANN, Klaus H, KURZEDER, Christian, SCHMALFELDT, Barbara, CIBULA, David

Volltext

Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review von Strojan, Primož, Vermorken, Jan B., Beitler, Jonathan J., Saba, Nabil F., Haigentz Jr, Missak, Bossi, Paolo, Worden, Francis P., Langendijk, Johannes A., Eisbruch, Avraham, Mendenhall, William M., Lee, Anne W. M., Harrison, Louis B., Bradford, Carol R., Smee, Robert, Silver, Carl E., Rinaldo, Alessandra, Ferlito, Alfio

Volltext

Cisplatin Eligibility Issues and Alternative Regimens in Locoregionally Advanced Head and Neck Cancer: Recommendations for Clinical Practice von Szturz, Petr, Cristina, Valerie, Herrera Gómez, Ruth Gabriela, Bourhis, Jean, Simon, Christian, Vermorken, Jan B

Volltext

A Review of the Most Promising Biomarkers in Colorectal Cancer: One Step Closer to Targeted Therapy von Deschoolmeester, Vanessa, Baay, Marc, Specenier, Pol, Lardon, Filip, Vermorken, Jan B.

Volltext

Oligometastatic Disease Management: Finding the Sweet Spot von Szturz, Petr, Nevens, Daan, Vermorken, Jan B.

Volltext

Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer von Szturz, Petr, Wouters, Kristien, Kiyota, Naomi, Tahara, Makoto, Prabhash, Kumar, Noronha, Vanita, Adelstein, David, Van Gestel, Dirk, Vermorken, Jan B

Volltext

Trabectedin Plus Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer von Monk, Bradley J, Herzog, Thomas J, Kaye, Stanley B, Krasner, Carolyn N, Vermorken, Jan B, Muggia, Franco M, Pujade-Lauraine, Eric, Lisyanskaya, Alla S, Makhson, Anatoly N, Rolski, Janusz, Gorbounova, Vera A, Ghatage, Prafull, Bidzinski, Mariusz, Shen, Keng, Ngan, Hextan Yuen-Sheung, Vergote, Ignace B, Nam, Joo-Hyun, Park, Youn Choi, Lebedinsky, Claudia A, Poveda, Andrés M

Volltext